Table 3.

Average Scores on Secondary Outcome Measures at Baseline and Discharge, and Comparison of Score Differences Between Baseline and Discharge From Rehabilitation for the BWSTT and Control Groups

Outcome	Values at Baseline		Values at Discharge		Values at Follow-up		Score Differences Between Baseline and Discharge			Score Differences Between Baseline and Follow-up
	BWSTT (n=14)	Control (n=7)	BWSTT (n=12)	Control (n=5)	BWSTT (n=10)	Control (n=4)	Estimate (SE)	95% CI	P	Estimate (SE)	95% CI	P
TUG (s)	73.5±29.1*	45.6±10.3†	25.2±7.0	20.7±5.0	18.0±6.8	12.8±0.9	−26.3 (23.4)	(−72.1, 19.6)	.32	−13.1 (16.7)	(−45.8, 19.7)	.45
2MWT (m)	18.7±18.9‡	23.6±15.3	70.6±17.3*	79.4±17.9	87.8±20.6§	51.2±59.4	−4.52 (10.0)	(−24.2, 15.1)	.66	38.1 (22.3)	(−5.7, 81.8)	.10
LEFS (score/80)||	16.6±8.0	25.7±16.5	35.3±7.5	46.4±7.2	45.4±9.4	48.0±4.4	0.08 (4.1)	(−8.0, 8.1)	.98	5.8 (5.4)	(−4.8, 16.5)	.30
FSES (score/40)¶	22.4±9.2	22.0±8.2	17.7±6.6	12.8±4.4	14.4±2.6	15.3±5.2	2.8 (3.3)	(−3.6, 9.2)	.40	−2.1 (4.7)	(−11.4, 7.1)	.66

NOTE. Values are mean ±SD or as otherwise indicated. Also, the n for each cell represents the value indicated in the column heading unless otherwise indicated. Abbreviations: CI, confidence interval; FSES, Falls Self-Efficacy Scale.

^*Valid n=8.

^†Valid n =4.

^‡Valid n=11.

^§Valid n=9.

^||A higher score indicates greater lower extremity function.

^¶A higher score indicates poorer falls self-efficacy.